Wrenlee Georgina
Tuberculosis (TB) remains a global health challenge, necessitating continuous advancements in treatment strategies. This abstract delves into recent breakthroughs in TB drug development, including novel compounds targeting drug-resistant strains and innovative delivery mechanisms to enhance efficacy and patient compliance. By exploring the latest research and clinical trials, this abstract highlights the promising avenues for revolutionizing TB treatment and ultimately reducing the burden of this infectious disease worldwide.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 